Section 4-41-402 - Cannabinoid sales and use authorized(1) The sale or use of a cannabinoid product is prohibited: (a) except as provided in this chapter; or(b) unless the United States Food and Drug Administration approves the product.(2) The department shall keep a list of registered cannabinoid products that the department has determined, in accordance with Section 4-41-403, are safe for human consumption.(3)(a) A person may sell or use a cannabinoid product that is in the list of registered cannabinoid products described in Subsection (2).(b) An individual may use cannabidiol or a cannabidiol product that is not in the list of registered cannabinoid products described in Subsection (2) if: (i) the individual purchased the product outside the state; and(ii) the product's contents do not violate Title 58, Chapter 37, Utah Controlled Substances Act.(4) Any marketing for a cannabinoid product shall include a notice to consumers that the product is hemp or CBD and is not cannabis or medical cannabis, as those terms are defined in Section 26B-4-201.(5) A cannabinoid product that is designed to be inhaled shall include a warning on the label regarding the possible health effects of inhaling cannabinoid products.Amended by Chapter 327, 2023 General Session ,§ 3, eff. 5/3/2023.Amended by Chapter 146, 2023 General Session ,§ 10, eff. 5/3/2023.Amended by Chapter 290, 2022 General Session ,§ 5, eff. 3/23/2022.Amended by Chapter 12, 2020 General Session ,§ 2, eff. 2/28/2020.Amended by Chapter 23, 2019 General Session ,§ 5, eff. 5/14/2019.Added by Chapter 452, 2018 General Session ,§ 4, eff. 5/8/2018.